75 FR 242 pg. 78997 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pilot Longitudinal Data Collection To Inform Public Health—Fragile X Syndrome, DD11-007, Initial Review
Type: NOTICEVolume: 75Number: 242Page: 78997
FR document: [FR Doc. 2010-31787 Filed 12-16-10; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pilot Longitudinal Data Collection To Inform Public Health-Fragile X Syndrome, DD11-007, Initial Review
In accordance with Section 10(a)(2) of the Federal AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11 a.m.-5 p.m., April 15, 2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of "Pilot Longitudinal Data Collection to Inform Public Health-Fragile X Syndrome, DD11-007, initial review."
Contact Person for More Information: Donald Blackman, PhD, Scientific Review Officer, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, GA 30341, Telephone: (770) 488-3023, E-mail: DBY7@cdc.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: December 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease Control and Prevention.
[FR Doc. 2010-31787 Filed 12-16-10; 8:45 am]
BILLING CODE 4163-18-P